CHICAGO, April 09, 2018 -- Liquidity Partners Trust I, a private real estate investment firm, is offering to pay approximately $3.1 million for up to 2,000,000 shares of InvenTrust Properties Corp. (“InvenTrust” or the “Company”) common stock for $1.55 per share. Shares may be redeemed via Liquidity Partners’ website, www.LiquidityPartners.net, which will provide a Medallion Signature Guarantee for sellers. The Offer to Purchase and Transfer Agreement are also located on Liquidity Partners’ website.
For questions, call (917) 338-1851, or email [email protected]. The tender offer will expire at 11:59 P.M. Eastern Time on May 14, 2018.
InvenTrust is a publicly-registered non-traded REIT and approved an unaudited and estimated net asset value per share of $3.29 for the Company’s common stock, effective May 1, 2017. On February 24, 2015, InvenTrust announced that its Share Repurchase Program was suspended indefinitely until further notice.
InvenTrust was incorporated as Inland American Real Estate Trust, Inc. in October 2004 and changed its name to InvenTrust Properties Corp. in April 2015. InvenTrust is a pure-play retail company with a focus on acquiring open-air shopping centers. As of December 31, 2017, InvenTrust’s portfolio consisted of 71 wholly-owned retail assets with a combined gross leasable area of approximately 12.4 million square feet. In April 2016, InvenTrust spun-off Highlands REIT, Inc. through a pro rata distribution of 100% of Highlands common stock to InvenTrust stockholders; and InvenTrust no longer owns any shares of common stock of Highlands.
If all shares in the current InvenTrust offer are tendered, Liquidity Partners Trust I will own approximately 0.286% of the common shares outstanding.


Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
Amazon Explores AI Content Marketplace With Media Publishers
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions 



